← Silence Therapeutics plc SLN
Market Price
$13.74
Market Cap
$660.81M
P/E Ratio
N/A
Revenue (FY 2025)
↓-98.7% YoY
$559.00K
3-Yr CAGR: -68.3%
Net Income
↓-95.6% YoY
-$88.61M
Net Margin: -15,851.9%
Free Cash Flow
↑8.1% YoY
-$62.33M
FCF Yield: -9.43%
EPS (Diluted)
↓-90.9% YoY
$-0.63
Basic: $-0.63
Return on Equity
Efficiency
-142.2%
ROA: -67.4%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (SLN)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2019 | $0.2M | — | $0.1M | $-22.9M | — | — | — | $1.7M | $1.7M | — |
| FY 2020 | $5.5M | +2,145.5% | $1.7M | $-36.0M | -57.6% | — | — | $-10.8M | $-11.3M | -757.0% |
| FY 2021 | $12.4M | +126.6% | $5.0M | $-45.9M | -27.2% | — | — | $6.8M | $5.5M | +148.7% |
| FY 2022 | $17.5M | +41.0% | $6.6M | $-47.4M | -3.3% | — | — | $-45.5M | $-45.6M | -929.8% |
| FY 2023 | $25.4M | +45.0% | $15.1M | $-50.3M | -6.2% | — | — | $-39.4M | $-39.4M | +13.6% |
| FY 2024 | $43.3M | +70.5% | $31.4M | $-45.3M | +9.9% | $-0.33 | — | $-67.6M | $-67.9M | -72.2% |
| FY 2025 | $0.6M | -98.7% | $0.3M | $-88.6M | -95.6% | $-0.63 | -90.9% | $-62.3M | $-62.3M | +8.1% |
Valuation
Market Price
$13.74
Market Cap
$660.81M
Enterprise Value
$649.77M
P/E Ratio
N/A
P/B Ratio
10.42
FCF Yield
-9.43%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
61.54%
Operating Margin
-16,292.84%
Net Margin
-15,851.88%
Return on Equity (ROE)
-142.23%
Return on Assets (ROA)
-67.42%
Asset Turnover
0.00x
Revenue 3-Yr CAGR
-68.27%
Financial Health & Liquidity
Current Ratio
8.72
Cash Ratio
0.83
Debt / Equity
0.004
Debt / Assets
0.002
Cash & Equivalents
$11.28M
Total Debt
$231.00K
Book Value / Share
$1.32
Cash Flow Efficiency
Operating Cash Flow
-$62.27M
Capital Expenditures (CapEx)
$55.00K
Free Cash Flow
-$62.33M
OCF / Revenue
-11,139.71%
FCF / Revenue
-11,149.55%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$-0.63
EPS (Basic)
$-0.63
Dividends / Share
N/A
Book Value / Share
$1.32
EPS YoY Growth
-90.91%
Balance Sheet (FY 2025)
Total Assets
$131.44M
Total Liabilities
$69.14M
Stockholders' Equity
$62.30M
Current Assets
$118.66M
Current Liabilities
$13.61M